Sustanon
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
347 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypogonadism | D007006 | — | E23.0 | 21 | 43 | 36 | 47 | 17 | 156 |
| Eunuchism | D005058 | EFO_0007266 | E29.1 | 5 | 8 | 11 | 11 | 2 | 35 |
| Prostatic neoplasms | D011471 | — | C61 | 4 | 19 | 1 | 2 | 2 | 28 |
| Healthy volunteers/patients | — | — | — | 7 | 3 | 2 | 2 | 2 | 14 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 2 | 2 | 2 | 5 | 3 | 13 |
| Insulin resistance | D007333 | EFO_0002614 | E88.819 | 4 | 2 | — | 3 | 2 | 10 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | 3 | 2 | 6 | — | 10 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 2 | 1 | 7 | — | 10 |
| Syndrome | D013577 | — | — | 2 | 1 | 1 | 3 | 2 | 9 |
| Psychological sexual dysfunctions | D020018 | — | F52.0 | 1 | 1 | 5 | 1 | 1 | 9 |
Show 53 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Gender dysphoria | D000068116 | — | F64 | 1 | 1 | 1 | — | 7 | 9 |
| Infertility | D007246 | EFO_0000545 | — | 1 | — | 2 | — | 3 | 6 |
| Spinal cord injuries | D013119 | EFO_1001919 | — | 2 | 5 | 1 | — | — | 6 |
| Aging | D000375 | GO_0007568 | R41.81 | 3 | 1 | 1 | — | — | 5 |
| Menopause | D008593 | EFO_0003922 | N95 | — | 4 | 1 | — | — | 5 |
| Neoplasms | D009369 | — | C80 | — | 2 | 2 | — | — | 4 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 3 | 1 | — | — | 4 |
| Critical illness | D016638 | — | — | — | 3 | 1 | — | 1 | 4 |
| Muscular atrophy | D009133 | — | — | — | 2 | 3 | — | — | 4 |
| Fatigue | D005221 | — | R53.83 | — | 3 | 1 | — | — | 4 |
Show 29 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Castration-resistant prostatic neoplasms | D064129 | — | — | 1 | 11 | — | — | — | 12 |
| Contraception | D003267 | — | — | 5 | 4 | — | — | — | 6 |
| Gonadal disorders | D006058 | — | — | 1 | 4 | — | — | 1 | 5 |
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | 2 | 1 | — | — | 1 | 4 |
| Androgen-insensitivity syndrome | D013734 | — | E34.5 | 1 | 3 | — | — | 1 | 4 |
| Sclerosis | D012598 | — | — | 1 | 4 | — | — | — | 4 |
| Carcinoma | D002277 | — | C80.0 | 2 | 1 | — | — | — | 3 |
| Osteoporosis | D010024 | EFO_0003882 | M81.0 | — | 2 | — | — | 1 | 3 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 2 | — | — | 1 | 3 |
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 3 | — | — | — | 3 |
Show 36 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | D006973 | EFO_0000537 | I10 | 2 | — | — | — | — | 2 |
| Facioscapulohumeral muscular dystrophy | D020391 | EFO_0000491 | G71.02 | 1 | — | — | — | — | 1 |
| Urologic neoplasms | D014571 | — | C64-C68 | 1 | — | — | — | — | 1 |
| Urologic diseases | D014570 | — | N39.9 | 1 | — | — | — | — | 1 |
| Urination disorders | D014555 | — | — | 1 | — | — | — | — | 1 |
| Sickle cell anemia | D000755 | EFO_0000697 | D57 | 1 | — | — | — | — | 1 |
| Priapism | D011317 | — | N48.3 | 1 | — | — | — | — | 1 |
| Virilism | D014770 | — | — | 1 | — | — | — | — | 1 |
| Squamous cell carcinoma | D002294 | — | — | 1 | — | — | — | — | 1 |
| Squamous cell neoplasms | D018307 | — | — | 1 | — | — | — | — | 1 |
Show 1 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Drug interactions | D004347 | — | — | — | — | — | — | 1 | 1 |
| Obstructive sleep apnea | D020181 | EFO_0003918 | G47.33 | — | — | — | — | 1 | 1 |
| Sleep apnea syndromes | D012891 | EFO_0003877 | G47.3 | — | — | — | — | 1 | 1 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | — | — | 1 | 1 |
| Fibrosis | D005355 | — | — | — | — | — | — | 1 | 1 |
| Duchenne muscular dystrophy | D020388 | EFO_0000429 | — | — | — | — | — | 1 | 1 |
| Muscular dystrophies | D009136 | EFO_0000757 | G71.0 | — | — | — | — | 1 | 1 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | — | — | — | 1 | 1 |
| Anxiety | D001007 | EFO_0005230 | F41.1 | — | — | — | — | 1 | 1 |
| Paraplegia | D010264 | — | G82.2 | — | — | — | — | 1 | 1 |
Show 19 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
55 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use